1. Home
  2. CCHH vs QNRX Comparison

CCHH vs QNRX Comparison

Compare CCHH & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCHH

CCH Holdings Ltd Ordinary Shares

N/A

Current Price

$0.51

Market Cap

10.2M

Sector

N/A

ML Signal

N/A

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$9.45

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCHH
QNRX
Founded
2015
2018
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2M
10.1M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
CCHH
QNRX
Price
$0.51
$9.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.8M
33.4K
Earning Date
02-10-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$9,138,264.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$38.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$5.01
52 Week High
$15.39
$41.80

Technical Indicators

Market Signals
Indicator
CCHH
QNRX
Relative Strength Index (RSI) 32.05 33.65
Support Level $0.48 $9.59
Resistance Level $0.83 $10.33
Average True Range (ATR) 0.06 0.86
MACD 0.26 -0.21
Stochastic Oscillator 22.07 7.10

Price Performance

Historical Comparison
CCHH
QNRX

About CCHH CCH Holdings Ltd Ordinary Shares

CCH Holdings Ltd operates a hotpot restaurant chain in Malaysia, specializing in chicken hotpot and fish head hotpot, mainly under two brand, namely Chicken Claypot House and Zi Wei Yuan, owned by the wholly owned subsidiaries of the Company. The Company conducts its operations through its wholly owned subsidiaries in Malaysia and is engaged as a restaurant operator, licensor and loyalty owner, and general trader. Currently, the Group has developed a restaurant chain including approximately 15 company-owned restaurant outlets, 13 franchised restaurant outlets in Malaysia, and 4 franchised restaurant outlets outside Malaysia.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: